Diabetes Devices Market in Global Industry: Overview, Size and Share 2020-2026

1
Diabetes Devices Market To Reach USD 38.53
Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Key factors contributing to the high CAGR are
increasing prevalence of diabetes and lack of
awareness. Further, aspects such as technological
progressions, product launches and collaborations
are fueling the market growth of diabetes
devices. Diabetes Device Market Size USD 21.93
Billion in 2018, Market Growth CAGR of 7.3,
Market Trends Product Launches and Research for
Advanced Tech Developments
3
Our Approach
Market Summary

• Based on current analysis, the global diabetes
  devices market was valued at USD21.93 billion in
  2018 and is expected to reach USD 38.53 billion
  by 2026, at a CAGR 7.3 Rising awareness about
  therapeutics for diabetes and diabetes management
  among patients is strengthening growth of the
  market. Continuous technological developments and
  advancements in the product is another factor
  expected to create potential opportunities in the
  market and continue over the forecast period. The
  diabetes devices offer a solution to diabetes
  affected patients manage the sugar level in the
  blood. diabetes device are devices used for
  checking the sugar level in the blood, it is also
  used to control glycemic improvement and
  reduction in hypoglycemia.
• Companies profiled for this market
  studyMedtronic, Insulet, Dexcom, Sanofi, Tandem,
  Ypsomed, Eli Lilly, Bayer Healthcare AG, Becton
  Dickinson and Company, Novo Nordisk A/S, Abbott
  Laboratories, F. Hoffman-La Roche AG and Johnson
  Johnson.
• Fill in your details to get your hands on an
  Exclusive Sample of this Report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /1488

4
Our Approach
Market Summary

• Key findings from the report
• Asia-Pacific is anticipated to grow enormously at
  CAGR of 8.2 during the forecast period, owing to
  factors, such as a high prevalence of diabetes,
  growing obese population, and government
  initiatives of raising awareness regarding
  diabetic care
• Medtronic PLC received the US Food and Drug
  Administration (FDA) approval for Guardian (TM)
  Connect continuous glucose monitoring (CGM)
  system, for people with diabetes aged between
  14-75 years. such market initiatives are proving
  to be profitable for the growth of diabetes
  device market
• Glucose monitoring devices dominated the diabetes
  devices market by registering 52 of market share
  in diabetes device productsContinued
• Any Query or Discount? Ask our Expert _at_
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/1488

5
Our Approach
Market Summary

• Type (Revenue in USD Million 20162026)
• Glucose Monitoring Devices
• Self- monitoring blood glucose meters
• Blood glucose testing strips
• Lancets
• Continuous glucose monitoring meters
• Insulin Delivery Devices
• Insulin syringes
• Insulin pens
• Insulin pumps
• Diabetes Management Software
• Artificial Pancreas System                        

6
Our Approach
Market Summary

• Distribution Channels (Revenue in USD Million
  20162026)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Diabetes Clinics/ Centers
• Others
• Regional Outlook (Revenue in USD Million
  20162026)
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and
  Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Read more _at_ https//www.reportsanddata.com/report-
  detail/diabetes-device-market

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com